High-precision diagnostic and operational products for modern research facilities.
Navigating the transition from site-centric to patient-centric digital research models.
The global clinical research landscape is undergoing a fundamental transformation. Traditional clinical trials, once tethered to physical sites and localized academic centers, are evolving into Decentralized Clinical Trial (DCT) models. As a leading manufacturer and exporter in this space, Dongguan Trial Medical Co., Ltd. is at the forefront of providing the hardware and software infrastructure necessary to facilitate this shift.
Our solutions integrate wearable health data collection, remote safety monitoring, and eCOA (electronic Clinical Outcome Assessment) platforms. By removing geographical barriers, we enable pharmaceutical companies and CROs (Contract Research Organizations) to reach broader patient populations, ensuring that life-saving treatments reach the market faster.
Post-pandemic, over 70% of clinical trials now incorporate at least one decentralized element. The industry is moving toward a "hybrid" model that combines remote data capture with essential site visits.
Unlike intermittent site visits, our remote monitoring devices provide continuous data streams, offering significant information gain and higher-resolution insights into patient health during the trial.
Adhering to FDA, EMA, and NMPA guidelines, our systems ensure data security (21 CFR Part 11) and patient privacy (GDPR/HIPAA), maintaining the highest levels of E-E-A-T in clinical technology.
How Dongguan's manufacturing excellence drives clinical innovation.
Located in the heart of the Greater Bay Area, Dongguan Trial Medical Co., Ltd. operates out of a state-of-the-art 11,000 square meter facility. Our "Factory 4.0" approach leverages advanced automation, IoT-integrated assembly lines, and real-time quality control systems to produce clinical-grade devices with unprecedented reliability.
What global buyers are looking for in the DCT landscape.
We are seeing a surge in "Site-less" trials in North America and Western Europe, driven by patient demand for remote participation. Additionally, "Bring Your Own Device" (BYOD) models are gaining traction to improve compliance.
Global buyers prioritize vendors who offer end-to-end support, including device logistics, international data hosting, and 24/7 technical support for trial participants across multiple time zones.
Localized language support and regional regulatory documentation (such as CE marking or TGA approval) are critical for successful implementation in diverse markets like Southeast Asia and Latin America.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability. In addition to its standard product offerings, the company provides OEM and ODM services tailored to specific research applications and market requirements.
Serving customers across North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa, Dongguan Trial Medical Co., Ltd. is committed to advancing digital clinical research through innovative technologies that support decentralized studies, patient-centric trial models, and data-driven healthcare innovation worldwide.
Insights into our clinical solutions and manufacturing capabilities.
Extended product range for global exporters and clinical laboratories.